Clinical Scenarios: Improving Awareness of PNH in Primary Care Settings – An In the Clinic Activity
hosted byIntegrity Continuing Education Inc.Clinical Scenarios: Improving Awareness of PNH in Primary Care Settings – An In the Clinic Activity is organized by Integrity Continuing Education Inc..
Release date: 31- 01- 2023
Expiration date: 31- 01- 2024
Description:
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare immunologic disorder that leads to the destruction of red blood cells through the complement cascade. Three complement inhibitors (CIs) are now available to treat this disorder which typically affects young adults during their most productive years and results in a high early mortality rate if not treated appropriately. With CIs, patients with PNH can now expect to live a relatively normal lifespan, but only if physicians and other members of the primary care team know how to recognize the signs and symptoms of this disease so patients can be referred to hematologist experts in PNH.
Learning Objectives:
Upon completion of this educational activity, participants should be able to:
- Identify symptoms, disease manifestations, and assessment criteria that indicate the need for PNH testing and referral to a hematology expert
- Describe the pathogenesis of PNH, the complement cascade, and complement inhibitors
- Devise a strategy for monitoring patients with PNH who are being treated with complement inhibitors
